tiprankstipranks

10x Genomics price target lowered to $60 from $75 at Citi

Citi analyst Patrick Donnelly lowered the firm’s price target on 10x Genomics to $60 from $75 and keeps a Buy rating on the shares post the Q3 report. The analyst says Xenium placements and orders continue to accelerate.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on TXG:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue